Intellia Therapeutics Stock Performance
as on September 26, 2026 at 2:15 pm IST
Day's Low
Day's High
$11.67$12.29
0.68%
Downside
4.60%
Upside
52 Week's Low
52 Week's High
$7.95$28.2532.34%
Downside
140.43%
Upside
Intellia Therapeutics share price movements today
- Previous Close
- $12.16
- Open
- $12.29
- Volume
- 2.2M
- Market Cap
- $1.7B
- Day's Low - High
- $11.67 - $12.29
- 52 Week Low - High
- $7.95 - $28.25
Intellia Therapeutics Historical Returns
- 1 Month Return
- -10.92 %
- 3 Month Return
- -29.56 %
- 1 Year Return
- -27.96 %
- 3 Year Return
- -63.68 %
- 5 Year Return
- -92.12 %
Intellia Therapeutics Stock Fundamentals & Key Indicators
Check Intellia Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.7B
EPS (TTM)
-3.36
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-3.62
Industry PE ratio
-8.07
PEG Ratio
-0.10093249203809306
EBITDA
-390.4M
Revenue (TTM)
59.5M
Profit Margin
-46.48%
Return On Equity TTM
-57.79%
Intellia Therapeutics Stock Valuation
Track how Intellia Therapeutics P/E has moved over time to understand its valuation trends.
Intellia Therapeutics in the last 5 years
Lowest (-31.29x)
December 31, 2021
Industry (-8.07x)
December 31, 2025
Today (-2.36x)
December 31, 2025
Highest (-2.22x)
December 31, 2024
Today’s Price to Earnings Ratio: -2.36x
Intellia Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Intellia Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $1.7B | -92.12% | -3.62 | -46.48% | 0.00% | |
| Neutral | $77.8B | -53.76% | -24.41 | -12.57% | 0.00% | |
| StrongBuy | $132.4B | 186.58% | 30.16 | 86.04% | 0.00% | |
| Buy | $82.8B | 23.34% | 19.01 | 84.86% | 0.46% |
Stock Returns calculator for Intellia Therapeutics Stock including INR - Dollar returns
The Intellia Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Intellia Therapeutics investment value today
Current value as on today
₹77,845
Returns
Returns from Intellia Therapeutics Stock
Dollar Impact
₹5,803 (+5.8%)
Analyst Recommendation on Intellia Therapeutics Stock
Based on 9 analysts
55.56%
Buy
22.22%
Hold
22.22%
Sell
Based on 9 analysts, 55.55555555555556% of analysts recommend a 'BUY' rating for Intellia Therapeutics. Average target price of $24
Intellia Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Intellia Therapeutics.
What analysts predicted
51.04%UPSIDE
Target Price
$24
Current Price
$11.75
Analyzed by
9 Analysts
High
$49
Target
$24.00
Low
$9
Intellia Therapeutics target price $24, a slight upside of 51.04% compared to current price of $11.75. According to 9 analysts rating.
Indian Investors' Interest in Intellia Therapeutics Stock
Investment in Intellia Therapeutics Shares on INDmoney has dropped by -2.61% in the last 30 days, indicating reduced investment activity.
Time period: to
Search interest for Intellia Therapeutics Stock has decreased by -8% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Intellia Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Intellia Therapeutics Annual Profit & Loss
All numbers in Millions USD
Intellia Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Intellia Therapeutics Annual Cash Flow
All numbers in Millions USD
Intellia Therapeutics News & Key Events
Today's Timeline - 08 September
Tue, 05:41 PM
-Intellia announces FDA acceptance of lonvo-z BLA with Priority Review and a target action date of March 10, 2027.
Insights on Intellia Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Moderna, Inc. Common Stock has given 102.7% return, outperforming this stock by 166.4%
- NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 712.1% return, outperforming this stock by 740.1%
NEGATIVE IMPACTPrice Dip
In the last 3 months, NTLA stock has moved down by -29.6%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 23.01M → 7.65M (in $), with an average decrease of 41.9% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -95.78M → -106.63M (in $), with an average decrease of 5.6% per quarter
About Intellia Therapeutics
| Organisation | Intellia Therapeutics |
| Headquarters | 40 Erie Street, Cambridge, MA, 02139, US |
| Industry | Biotechnology |
| CEO | John Leonard |
| E-voting on shares | Click here to vote |
Key Management of Intellia Therapeutics
Name | Title |
|---|---|
Dr. Rodolphe Barrangou M.B.A., Ph.D. | Founder & Member of Scientific Advisor Board |
Prof. Luciano Marraffini Ph.D. | Founder & Member of Scientific Advisor Board |
Mr. Michael P. Dube | VP & Chief Accounting Officer |
Dr. John M. Leonard M.D. | President, CEO & Director |
Mr. James E. Basta Esq., J.D. | Executive VP, General Counsel & Corporate Secretary |
Dr. Jennifer A. Doudna Ph.D. | Founder & Member of Scientific Advisor Board |
Mr. Erik J. Sontheimer Ph.D. | Founder & Member of Scientific Advisor Board |
Dr. Birgit Schultes Ph.D. | Executive VP & Chief Scientific Officer |
Dr. Rachel E. Haurwitz Ph.D. | Co-Founder |
Dr. Derrick J. Rossi Ph.D. | Founder & Member of Scientific Advisor Board |
FAQs
What is Intellia Therapeutics share price today?
Intellia Therapeutics share price today is $11.75 as on at the close of the market. Intellia Therapeutics share today touched a day high of $12.29 and a low of $11.67.
What is the 52 week high and 52 week low for Intellia Therapeutics share?
Intellia Therapeutics share touched a 52 week high of $28.25 on and a 52 week low of $7.95 on . Intellia Therapeutics stock price today i.e. is closed at $11.75,which is 58.41% down from its 52 week high and 47.80% up from its 52 week low.
What is Intellia Therapeutics's market capitalisation today?
Intellia Therapeutics market capitalisation is $0.00T as on .
How to invest in Intellia Therapeutics Stock (NTLA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Intellia Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Intellia Therapeutics Shares that will get you 0.1277 shares as per Intellia Therapeutics share price of $11.75 per share as on September 26, 2026 at 8:45 am IST.
What is the minimum amount required to buy Intellia Therapeutics Stock (NTLA) from India?
Indian investors can start investing in Intellia Therapeutics (NTLA) shares with as little as ₹95.819999694824 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.20 in Intellia Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Intellia Therapeutics share’s latest price of $11.75 as on September 26, 2026 at 8:45 am IST, you will get 0.8511 shares of Intellia Therapeutics. Learn more about
fractional shares .
What are the returns that Intellia Therapeutics has given to Indian investors in the last 5 years?
Intellia Therapeutics stock has given -92.12% share price returns and 29.7% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?